ABT-806, the parental antibody of ABT-414, was found to accumulate specifically in the tumor in both mouse models and in patients with glioma [58, 59] and showed impressive antitumor activity in GBM xenografts harboring EGFR amplification or EGFRvIII [60]. Here, EGFR is linked to central nervous system cancer.